Cassava Sciences Inc (SAVA)

Millions of Americans are struggling with Alzheimer's, according to the Alzheimer’s Association. The disease often has a slow progression, lasting years or even decades, and it's…

What to Do After Cassava Sciences Dropped Off a Cliff

By Chris Lau, InvestorPlace Contributor Aug 9, 2021

Cassava Sciences posted positive clinical data but triggered a sell on the news event, as SAVA stock short sellers welcomed the drop.

Cassava Sciences Stock Has Been Hammered For No Good Reason and Is Likely To Rebound

By Mark R. Hake, CFA Aug 3, 2021

Cassava Sciences stock has been hammered for no good reason and is likely to rebound. AVA stock is still worth over $900 especially given the recent positive 9-month results of its Alzheimer's drug Simufilam.

Midday Market Update: Why Are Stocks Down Today?

By William White, InvestorPlace Writer Jul 30, 2021

The stock market isn't doing so hot on Friday as market worries continue to weigh on investors in our midday update today.

Cassava Sciences Stock Has Plenty of Momentum After Positive Clinical Data

By Louis Navellier and the InvestorPlace Research Staff Jul 29, 2021

As Cassava Sciences made progress in treating Alzheimer's, SAVA stock is on a powerful path to significantly higher prices.

Cassava Sciences Stock Could Be Worth $900 After Its Upcoming Alzheimer’s Results

By Mark R. Hake, CFA Jul 23, 2021

Cassava Sciences stock could jump with its upcoming Alzheimer's results. SAVA stock options show the lofty expectations investors have.

Midday Market Update: What Are the Top Performing Stocks Today?

By William White, InvestorPlace Writer Jul 21, 2021

We're over halfway through the day and that means it's time to check in on what the top-performing stocks are doing on Wednesday.

SAVA Stock: Two Dates Cassava Investors Need to Mark on Their Calendars

By Brenden Rearick, InvestorPlace Financial News Writer Jul 21, 2021

SAVA stock is flying upward today as investors clamor to hear information around two new products. Investors should save two upcoming dates.

7 Top-Rated Pharmaceutical Companies to Invest In for July

By Louis Navellier and the InvestorPlace Research Staff Jul 9, 2021

Pharma stocks like MNMD stock and ANVS stock offer investors long-term growth potential in a market on track to hit a value of $1.70 trillion.

3 Better Alzheimer’s Drug Stocks to Buy Instead of Biogen

By Muslim Farooque, InvestorPlace Contributor Jun 29, 2021

These drug stocks are in competition with Biogen for an Alzheimer's treatment, and can break out in a similar fashion offering better value.

Midday Market Update: The 10 Biggest Gainers Today

By William White, InvestorPlace Writer Jun 7, 2021

Monday's already halfway over and that means it's time for a midday market update with meme stocks rising higher on a rally today.

7 High-Flying Stocks That Could Crash 20% or Even More

By Josh Enomoto, InvestorPlace Contributor Mar 19, 2021

If nothing happens – and that’s the hope – this article will be nothing but a good laugh. However, astute investors should at least know about these stocks that could crash.